GBM cells exhibit heightened levels of PD-L1, leading to effective binding with PD-1 and consequently promoting tumor growth and enabling the tumor cells to resist CD8 cytotoxic cells and evade immune destruction [42]. The gene discussed is CD8A; the disease is glioblastoma.